| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Experimental Research Laboratory, Division of Cardiology, University of Louisville, Louisville, Kentucky 40292
 |
ABSTRACT |
|---|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
It is unknown whether ischemic preconditioning (PC; either early or late) occurs in the mouse. The goal of this study was to answer this question and to develop a reliable and physiologically relevant murine model of both early and late ischemic PC. A total of 201 mice were used. In nonpreconditioned open-chest animals subjected to 30 min of coronary occlusion followed by 24 h of reperfusion, infarct size (tetrazolium staining) averaged 52% of the region at risk. When the 30-min occlusion was performed 10 min after a PC protocol consisting of six cycles of 4-min occlusion and 4-min reperfusion, infarct size was reduced by 75%, indicating an early PC effect. When the 30-min occlusion was performed 24 h after the same PC protocol, infarct size was reduced by 48%, indicating a late PC effect. In mice in which the 30-min occlusion was followed by 4 h of reperfusion, infarct size was similar to that observed after 24 h of reperfusion, indicating that a 4-h reperfusion interval is sufficient to detect the final extent of cell death in this model. Fundamental physiological variables (body temperature, arterial oxygenation, acid-base balance, heart rate, and arterial pressure) were measured and found to be within normal limits. Taken together, these results demonstrate that, in the mouse, a robust infarct-sparing effect occurs during both the early and the late phases of ischemic PC, although the early phase is more powerful. This murine model is physiologically relevant, provides reliable measurements, and should be useful for elucidating the cellular mechanisms of ischemic PC in genetically engineered animals.
coronary occlusion; coronary reperfusion; transgenic animals; knockout animals; genetic manipulations
| |
INTRODUCTION |
|---|
|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
ISCHEMIC PRECONDITIONING (PC) is a powerful cardioprotective mechanism that confers relative resistance against myocellular death resulting from ischemia-reperfusion injury (1, 13, 16, 31, 33). The time course of ischemic PC is characterized by an immediate but short-lived wave of protection (early phase of PC) (1, 11, 13, 14, 16, 33, 38) followed, 12-24 h later, by a second, sustained window of protection that lasts at least 72 h (late phase of PC) (3-6, 9, 10, 27, 29-31, 36, 38, 45, 46, 48, 49, 55). Because of its remarkable efficacy, there is considerable interest in exploiting ischemic PC to develop therapeutic strategies that can enhance the tolerance of the heart to ischemic injury in patients with coronary artery disease (8, 13, 16, 31). Clinical application of ischemic PC, however, will require a detailed understanding of the molecular and cellular mechanisms underlying this endogenous adaptive phenomenon.
It is now apparent that activation of cellular kinases (e.g., protein kinase C and mitogen-activated protein kinases) plays an important role in both the early and the late phases of ischemic PC (3, 6, 13, 15, 16, 23, 31, 36, 37, 53, 56) and that upregulation of cardioprotective genes underlies the development of late PC (10, 30, 31, 40, 48). The specific isoforms of kinases involved, however, remain to be identified. Similarly, definitive evidence for a cause-and-effect relationship between the activity of a specific gene and the development of late PC is still lacking. Solving these issues with pharmacological approaches would be difficult because most inhibitors are not entirely specific and do not completely inhibit the target kinase or transcription factor. In contrast, genetic manipulations that either overexpress or disrupt a gene (transgenesis and gene targeting) can provide conclusive demonstration of the causative role of a gene product in ischemic PC. Thus the use of transgenesis and gene targeting for interrogating the function of individual proteins would be a powerful approach to investigating the mechanism of ischemic PC.
The mouse is the species commonly used for transgenesis and gene targeting. Although transgenesis is theoretically possible in larger mammals (e.g., rabbits or pigs), developing such models would be extremely costly and would require considerable time, making these models impractical. Furthermore, gene targeting has not been reported thus far in species other than the mouse. Thus, to utilize both transgenesis and gene targeting to study ischemic PC, it is necessary to use mice. Murine models of myocardial infarction have been developed in previous studies (22, 32). However, to our knowledge, it is unknown whether ischemic PC (either early or late) occurs in the mouse. This issue is particularly important with respect to the late phase of ischemic PC, which has been suggested to be species dependent because it has been observed in dogs (27) and rabbits (3-5, 30, 38, 48, 55) but not in pigs (39) or rats (24). Furthermore, the unique technical challenges associated with inducing infarctions in mice raise the concern that the results obtained in this model may not be as reliable and physiological as those obtained in larger species, in which the margin for error is wider and physiological parameters can be measured more easily.
Accordingly, the goals of the present study were 1) to determine whether the early and the late phases of ischemic PC exist in the mouse; 2) if so, to compare their relative potencies; 3) to establish whether the magnitude of the PC protection can be accurately assessed with reperfusion intervals as short as 4 h or whether survival surgery (24 h of reperfusion) is required; and 4) to develop reliable murine models of early and late PC in which fundamental physiological variables (body temperature, oxygenation, acid-base balance, heart rate, and arterial blood pressure) are carefully controlled and kept within normal values.
| |
METHODS |
|---|
|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
This study was performed in accordance with the guidelines of the Animal Care and Use Committee of the University of Louisville School of Medicine and with the Guide for the Care and Use of Laboratory Animals [DHHS Publication No. (NIH) 86-23].
Experimental preparation. Male ICR (Institute of Cancer Research) mice (weight 33.3 ± 0.5 g; age 8-12 wk) were obtained from Harlan Sprague Dawley (Houston, TX) and housed under specific pathogen-free conditions in a room with a 24°C temperature, 55-65% relative humidity, and a 12:12-h light-dark cycle. Mice were premedicated with atropine sulfate (0.04 mg/kg im) and anesthetized 5 min later with pentobarbital sodium (50 mg/kg ip). Additional doses of pentobarbital were given during the protocol as needed to maintain anesthesia. The animals were placed in a supine position with the paws taped to the operating table. Surface leads were placed subcutaneously to obtain the electrocardiogram (ECG), which was recorded throughout the experiments on a thermal array chart recorder (Gould TA6000). Before surgery started, mice were given gentamicin (0.7 mg/kg im).
A midline cervical skin incision was performed, and the muscles overlying the trachea were reflected to allow visualization of the endotracheal tube (PE-60 tubing) as it was placed in the trachea. To facilitate intubation, a rubber band was placed behind the upper incisors and fastened to the operating table so that the neck was slightly extended. To place the endotracheal tube, the tongue was slightly retracted, and the beveled end of the tube (which was marked with a black marker) was inserted through the larynx and into the trachea with care taken not to puncture the trachea or other structures in the pharyngeal region. The tube was advanced 8-10 mm from the larynx and taped in place to prevent dislodgment. The animals were ventilated with room air supplemented with oxygen (2 l/min) at a rate of 105 breaths/min and with a tidal volume of 2.1-2.5 ml using a rodent ventilator (Harvard Apparatus, South Natick, MA). The endotracheal tube was inserted loosely into the tube connected to the ventilator so as to avoid lung overexpansion. A catheter was inserted into the external jugular vein for fluid infusion. In selected studies, a catheter was inserted into the carotid artery for measurement of blood pressure (DTX pressure transducer, Viggo-Spectramed, Oxnard, CA) and analysis of blood gases. To replace blood losses, blood from a donor mouse was given intravenously at a dose of 40 ml/kg (~1 ml) divided into three equal boluses (first bolus, after the endotracheal tube was connected to the ventilator; second bolus, after the chest was opened; third bolus, after the chest was closed). Body temperature was carefully monitored with a rectal probe connected to a digital thermometer (Cole-Parmer Instrument, Vernon Hill, IL) and was maintained as close as possible to 37.0°C throughout the experiment by using a heating pad and heat lamps. With the aid of a dissecting microscope (Fisher Scientific, Pittsburgh, PA) and a microcoagulator (ASSI Polar-Mate Isolator, San Diego, CA), the chest was opened through a midline sternotomy. An 8-0 nylon suture was passed with a tapered needle under the left anterior descending coronary artery 2-3 mm from the tip of the left auricle, and a nontraumatic balloon occluder was applied on the artery. Coronary occlusion was induced by inflating the balloon occluder. Successful performance of coronary occlusion and reperfusion was verified by visual inspection (i.e., by noting the development of a pale color in the distal myocardium on inflation of the balloon and the return of a bright red color due to hyperemia after deflation) and by observing S-T segment elevation and widening of the QRS on the ECG during ischemia and their resolution after reperfusion. After the coronary occlusion-reperfusion protocol was completed, the chest was closed in layers, and a small catheter was left in the thorax for 10-20 min to evacuate air and fluids. The mice were removed from the ventilator, kept warm with heat lamps, given fluids (1.0-1.5 ml of 5% dextrose in water intraperitoneally), and allowed 100% oxygen via nasal cone.Experimental protocol. Ischemic PC was produced with a sequence of six cycles of 4-min coronary occlusion and 4-min reperfusion (Fig. 1). This protocol was selected because it has proved highly effective in inducing late PC in rabbits (38, 48). Myocardial infarction was produced by a 30-min coronary occlusion followed by either 4 or 24 h of reperfusion. A 30-min occlusion was selected because in pilot studies it produced infarcts averaging ~50% of the risk region in control animals, which enabled us to detect either a detrimental or a beneficial effect of the intervention examined.
|
Postmortem tissue analysis. At the conclusion of the study, the mice were given heparin (1 U/g ip), after which they were anesthetized with pentobarbital sodium (35 mg/kg iv) and euthanized with an intravenous bolus of KCl. The heart was excised and perfused with Krebs-Henseleit solution through an aortic cannula (22- or 23-gauge needle) using a Langendorff apparatus. To delineate infarcted from viable myocardium, the heart was then perfused with a 1% solution of 2,3,5-triphenyltetrazolium chloride in phosphate buffer (pH 7.4, 37°C) at a pressure of 60 mmHg (~3 ml over 3 min). To delineate the occluded-reperfused coronary vascular bed, the coronary artery was then tied at the site of the previous occlusion and the aortic root was perfused with a 5% solution of phthalo blue dye (Heucotech, Fairless Hill, PA) in normal saline (2 ml over 3 min). As a result of this procedure, the portion of the left ventricle (LV) supplied by the previously occluded coronary artery (region at risk) was identified by the absence of blue dye, whereas the rest of the LV was stained dark blue (Figs. 2-4). The heart was frozen, after which all atrial and right ventricular tissues were excised. The LV was cut into 5-7 transverse slices, which were fixed in 10% neutral buffered formaldehyde and, 24 h later, weighed and photographed (Nikon AF N6006). The transparencies were projected onto a paper screen at ×30 magnification, and the borders of the infarcted, ischemic reperfused, and nonischemic regions were traced. The corresponding areas were measured by computerized videoplanimetry (Adobe Photoshop, version 4.0), and from these measurements infarct size was calculated as a percentage of the region at risk using methods analogous to those employed in previous studies (2, 35, 38, 39, 48).
|
|
|
Statistical analysis. Data are reported as means ± SE. Heart rate and body temperature were analyzed with a two-way repeated-measures ANOVA (time and group). Infarct size and risk region size were analyzed with a one-way ANOVA followed by unpaired Student's t-tests with the Bonferroni correction (51). The relationship between infarct size and risk region size was compared among groups with an analysis of covariance (ANCOVA), with the size of the risk region as the covariate (38). The correlation between infarct size and risk region size was assessed by linear regression analysis using the least-squares method. All statistical analyses were performed using the SAS software system (41). Two-way ANOVA was performed using the general linear models procedure (41).
| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
A total of 201 mice were used in this investigation (47 for the pilot studies and 154 for the studies of ischemic PC).
Pilot studies. Initially, we induced anesthesia with xylazine (7.5 mg/kg im) and ketamine (55 mg/kg im); however, we found that the heart rate was quite low (280-330 beats/min), which was clearly nonphysiological. We therefore chose pentobarbital anesthesia, as used by Michael et al. (32). After the anesthetic was selected, a series of pilot studies was performed in 47 mice. First, we sought to establish physiological parameters to be used as a reference for subsequent experiments. In eight mice, ECG leads were placed subcutaneously and the animals allowed to recover. Heart rate was monitored in the conscious state on the following days and was found to average 668 ± 31 beats/min (range 490-760 beats/min). In 16 pentobarbital-anesthetized mice, mean arterial blood pressure before thoracotomy was found to average 97.2 ± 4.4 mmHg. In 39 pentobarbital-anesthetized mice, rectal temperature before thoracotomy was found to average 37.0 ± 0.4°C. In subsequent studies, the experimental conditions were adjusted to maintain heart rate, arterial blood pressure, and body temperature as close as possible to these values.
Another series of pilot studies was performed to identify the optimal ventilatory parameters. Because the endotracheal tube used was without a cuff, the tidal volume was adjusted by observing the inflation of the lungs after the chest was opened. We found that an average tidal volume of 2.2 ± 0.1 ml resulted in adequate inflation of the lungs without overexpansion. With the use of this tidal volume, different ventilatory rates were tested in 23 open-chest mice and arterial blood gases were analyzed in each animal (Table 1). The results showed that even small changes in ventilatory rate resulted in significant changes in arterial blood gases (Table 1), emphasizing the importance of these measurements. A ventilatory rate of 105 breaths/min was found to produce optimal values of arterial PO2, PCO2, and pH, as detailed in Table 1. This rate is within the range observed in spontaneously breathing mice (25, 54). Accordingly, this rate was used in the present study.
|
80
mmHg throughout a 1-h period of open-chest state (Fig. 5). Next, we
tested whether this protocol of fluid replacement was sufficient to
prevent severe hypotension in mice undergoing the sequence of six
coronary occlusion-reperfusion cycles in which myocardial
ischemia would be expected to cause a further drop in arterial
pressure. Although each coronary occlusion caused a drop in arterial
pressure, the three doses of blood resulted in mean arterial pressure
being maintained 80 mmHg throughout the six occlusion-reperfusion
cycles (Fig. 5). Thus, with the fluid supplementation protocol detailed
above and with careful precautions taken to minimize blood losses,
arterial blood pressure could be kept at adequate levels throughout the
six occlusion-reperfusion cycles.
|
Exclusions. A total of 154 mice were used for the studies of ischemic PC. Twenty-one mice died because of hemorrhage (n = 5), pneumothorax (n = 6), pentobarbital overdose (n = 1), or other reasons (n = 9). Five mice died of ventricular fibrillation or presumed arrhythmias or heart failure during coronary occlusion or during the first 2 h of reperfusion: one in group I (control, 4-h reperfusion), one in group II (control, 24-h reperfusion), one in group III (early PC sham), and two in group VI (late PC, 4-h reperfusion). Thirty-six mice (23%) were excluded because of technical problems, including body temperature out of normal range (n = 2), malfunction of the ventilation system (n = 5), damage to the coronary vessels (n = 6), inadequate postmortem staining (n = 5), balloon malfunction (n = 13), and postoperative complications or other technical problems (n = 5). Ninety-two mice successfully completed the entire protocol and were included in the analysis of region at risk and infarct size. Thus total mortality (surgical mortality plus mortality due to coronary occlusion-reperfusion) was 17% (26 of 154).
Body temperature and heart rate. Rectal temperature was controlled strictly throughout the experiment with the use of heat lamps and a heating pad. As a result, temperature remained within a narrow, physiological range (36.4-37.6°C) in all groups (Table 2). Heart rate remained stable throughout the protocol in each group (Table 2). Although in some groups the heart rate was 10-20% lower than the average heart rate measured in the pilot studies in conscious mice (668 ± 31 beats/min), it was still within the range of measurements obtained in these pilot studies (490-760 beats/min). Heart rate did not differ significantly among the four groups in which the 30-min coronary occlusion was performed on day 1 (groups I-IV). In the four groups in which the 30-min coronary occlusion was performed on day 2 (groups V-VIII), the heart rate was 10-20% higher than the corresponding values measured on day 1 in groups I-IV (Table 2), possibly reflecting the effect of the surgical trauma 24 h earlier. However, there was no statistically significant difference among groups V-VIII.
|
Region at risk and infarct size. There were no significant differences among the eight groups with respect to LV weight or weight of the region at risk (Table 3). In group I, the 30 min of coronary occlusion followed by 4 h of reperfusion resulted in an infarct size of 50.9 ± 2.6% of the region at risk (Fig. 6). Similar results were obtained in group II, which underwent 30 min of coronary occlusion and 24 h of reperfusion (53.2 ± 3.6% of the region at risk) (Fig. 6), indicating that the assessment of cell death at 4 h represents the final extent of myocardial infarction in this model. A representative example of the infarctions observed in group II is shown in Fig. 2. The large, confluent areas of infarction spanning most of the thickness of the LV wall, with thin rims of viable subendocardial tissue, were characteristic of all five nonpreconditioned groups (groups I-III, V, and VII).
|
|
|
0.90 and the differences <5%
(n = 30 mice). These data demonstrate
that the measurements of infarct size in our mouse model are highly
reproducible.
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
The purpose of this study was to develop a reliable and physiologically relevant model of ischemic PC that can be used in genetically engineered animals. Our results can be summarized as follows: 1) in the mouse, a sequence of six cycles of 4-min coronary occlusion and 4-min reperfusion induces a powerful infarct-sparing effect during both the early and the late phases of ischemic PC; 2) the magnitude of the protection afforded by the early phase of PC (~75% reduction in infarct size) is greater than that afforded by the late phase of PC (~48-55% reduction in infarct size); 3) in both nonpreconditioned and preconditioned mice, the size of the infarct is similar after 4 and 24 h of reperfusion following the 30-min occlusion, indicating that a 4-h reperfusion interval is sufficient to assess ischemic PC in this model; 4) despite the small size of the mouse, it is possible to study ischemic PC in this model under conditions in which basic physiological variables (body temperature, arterial oxygenation, acid-base balance, heart rate, and arterial blood pressure) are kept within normal limits; and 5) both the quality of the postmortem staining for region at risk and infarction and the reproducibility of the measurements of infarct size are excellent and compare favorably with those in larger species.
Previous studies have demonstrated that myocardial infarction can be produced and quantitated in mice (22, 32). To our knowledge, this is the first study to demonstrate that ischemic PC (either early or late) exists in the mouse. This murine model of early and late PC should be useful for investigating the impact of genetic manipulations on physiological end points in vivo. By applying this model to mice with overexpression or targeted disruption of individual genes implicated in the cellular pathways underlying ischemic PC, it should be possible to conclusively establish the role of a specific gene product in the genesis of PC in the intact animal.
Physiological relevance of model. A major concern in the design of these experiments was to ensure that the results would be physiologically relevant. The minuscule size of the murine heart necessitates miniaturization of the procedures used in larger species and therefore poses a unique challenge in terms of maintaining general experimental conditions within normal values and avoiding artifacts. In the present study, a considerable amount of preliminary work (summarized in Pilot studies) was performed before ischemic PC was investigated. Because temperature is a major determinant of infarct size (12, 17, 20, 43), this variable was tightly controlled throughout the experiment by using heating pads and heat lamps while continuously monitoring rectal temperature. Our results demonstrate that, with the use of these procedures, temperature was kept within a narrow range (36.4-37.6°C; Table 2) that represents the normal range for the mouse (25, 44), as confirmed by our pilot studies, in which rectal temperature averaged 37.0 ± 0.4°C. Hypoxemia, acidosis, and alkalosis may also have a major influence on animal survival, infarct size, and/or ischemic PC. Accordingly, we measured arterial pH, PO2, PCO2, and bicarbonate levels in mice subjected to open-chest surgery (Table 1). These measurements demonstrated that, with a ventilatory rate of 105 breaths/min and an average tidal volume of 2.2 ml, all parameters were within the physiological range for the mouse (18); in particular, arterial pH was kept at ~7.40 and adequate oxygenation was maintained throughout the open-chest state (Table 1). Careful control of blood gases is important in the mouse, because small variations in ventilatory rate result in marked variations in arterial blood gases (Table 1).
Heart rate and arterial pressure are important indexes of normal cardiovascular homeostasis and are also important determinants of the severity of myocardial ischemia. As elaborated in RESULTS, we avoided anesthesia with ketamine-xylazine because these agents resulted in unacceptably low heart rates (280-330 beats/min), clearly outside of the physiological range, which in our pilot studies in conscious mice was found to be 490-760 beats/min (average 688 ± 31 beats/min). With the use of pentobarbital anesthesia, the heart rates recorded in the present experiments (Table 2) were reasonably close to those measured in conscious mice in our pilot studies and in prior studies (18, 25, 28, 42, 44, 47, 54). The blood volume of a 25-g mouse has been estimated to range between 1.5 and 2.3 ml (25). To avoid hypotension, surgery was performed with a microcoagulator and every effort was made to minimize blood losses. Pilot studies, however, showed that opening the chest caused a significant drop in arterial blood pressure so that the mice became severely hypotensive despite the administration of 13.3 ml/kg (~0.4 ml) of blood (Fig. 5). Besides causing mortality, severe hypotension could lead to myocardial hypoperfusion and, possibly, induce PC as a result of myocardial ischemia and/or reflex adrenergic activation. We therefore modified our protocol by administering three doses of blood (total of 40 ml/kg or ~1.2 ml), as detailed in METHODS, which resulted in values of mean arterial blood pressure >80 mmHg throughout a sequence of six coronary occlusion-reperfusion cycles (Fig. 5). These values of arterial pressure are within the range reported by others in normal mice (19, 21, 25, 26, 28, 34, 42, 47, 50, 52). Therefore, it is unlikely that the sequence of six cycles of occlusion-reperfusion produced PC because of hypotension-induced ischemia. Such a possibility was further ruled out by the results obtained in sham-preconditioned mice (groups III, V, and VII).Comparison with previous studies. Besides the physiological relevance of the model, the reliability of the measurements of infarct size was felt to be of paramount importance in the outcome of the present investigation. Several modifications of the postmortem perfusion technique were implemented during the development of this protocol, which led to a progressive improvement in tissue staining. The final protocol described in METHODS resulted in excellent staining and clear delineation of both region at risk and infarction, as shown in Figs. 2-4. On the basis of the quality of the staining, we feel that the precision of the measurements of infarct size was at least equal to that previously achieved in our laboratory in dogs (35), pigs (39), and rabbits (2, 38, 48). This conclusion is further corroborated by the small interobserver and intraobserver variabilities in our infarct size measurements, as detailed in RESULTS. These considerations indicate that the results obtained in this murine model are accurate and reproducible.
With the use of this model, the average infarct size in nonpreconditioned mice (groups I-III, V, and VII combined) was found to be 52% of the region at risk, which is similar to the average infarct size measured after the same duration of coronary occlusion (30 min) in conscious rabbits [56.9 ± 5.9% (Ref. 38) and 56.8 ± 5.3% (Ref. 48) of the region at risk] and in open-chest rabbits [52.0 ± 5.2% (Ref. 30), 53.6 ± 5.7% (Ref. 5), 48.1 ± 3.9% (Ref. 4), and 49.1 ± 4.3% (Ref. 3) of the region at risk]. The ranges of individual infarct sizes (Fig. 6) and the slopes and x-intercepts of the infarct size-risk region relationships (Fig. 7) were also similar to those previously observed in conscious rabbits after a 30-min occlusion (38, 48). The average infarct size measured in nonpreconditioned mice in this study (52% of the risk region) is larger than that reported by Michael et al. (32) in nonpreconditioned mice subjected to 30 min of occlusion and 24 h of reperfusion (34.4 ± 9.2%) and by Hutter et al. (22) in six nonpreconditioned mice subjected to 30 min of occlusion and 2 h of reperfusion (33.4 ± 4.5%). The reason(s) for the differences between these previous studies (22, 32) and the present results is unknown. Differences in body temperature might be a factor. Because in these investigations (22, 32) the heart rate was not reported and arterial blood pressure, arterial pH, and arterial PO2 were not measured, it is not possible to compare these variables with the heart rate, arterial pressure, arterial pH, and arterial PO2 in our study.Early and late PC in mice. Although the early phase of ischemic PC has been consistently observed in every species studied heretofore (1, 13, 16), controversy persists as to whether late PC is a universal or a species-specific phenomenon, since this phase of ischemic PC has been reported in canines (27) and rabbits (3-5, 30, 38, 48, 55) but not in pigs (39) or rats (24). The present results clearly demonstrate that a robust PC effect can be induced in mice during both the early and the late phases of protection. The magnitude of the infarct-sparing effect afforded by early PC (~75% reduction in average infarct size) was impressive. The protection afforded by the late phase of PC was also quite powerful (~48-55% reduction in average infarct size) (Fig. 6). The magnitude of the early and late infarct-sparing effects was roughly comparable to that reported in most previous studies in larger species (1, 5, 11, 13, 14, 16, 27, 30, 31, 33, 38, 39, 48). The design of the present investigation enabled us to perform a direct comparison between the relative potencies of the early and the late phase of ischemic PC, because the same experimental conditions and techniques and the same ischemic PC protocol (six cycles of 4-min occlusion and 4-min reperfusion) were used to study both phases. As shown in Fig. 6, the average reduction in infarct size afforded by early PC in group IV was greater than that afforded by late PC in group VIII; also, the spread of the data around the mean was less in group IV than in group VIII, indicating more consistent protection (Fig. 6). It therefore appears that, in the mouse, the infarct-sparing effects of early PC are more powerful than those of late PC, which is consistent with the observations made in other species (1, 3-5, 11, 13-16, 23, 27, 30, 31, 33, 38, 39, 48, 53, 55, 56).
To rule out the possibility that the PC effects could have been induced by the surgical procedure rather than by ischemia, we studied three groups of sham-preconditioned animals: group III (early PC sham), in which the chest was left open for 60 min immediately before the 30-min coronary occlusion, and groups V (late PC sham, 4-h reperfusion) and VII (late PC sham, 24-h reperfusion), in which the chest was left open for 60 min 24 h before the 30-min occlusion. In these groups, a suture was placed under the coronary artery and, in groups V and VII, left in place for 24 h, just as in the preconditioned groups. The fact that infarct size in groups III, V, and VII was indistinguishable from that in control mice that were not subjected to the 60-min open-chest state (groups I and II) (Fig. 6) demonstrates that neither the stress of surgery nor the placement of the suture was sufficient to elicit a PC effect. In view of the added complexity inherent in following mice for 24 h after reperfusion, we investigated whether extending the reflow period beyond 4 h was important for assessing the final extent of infarct size. Birnbaum et al. (7) have reported that at least 3 h of reperfusion are necessary to assess the final extent of infarction in rabbits. Accordingly, we allowed a minimum of 4 h of reperfusion. When infarct size was compared after 4 and 24 h of reperfusion, the results were similar in both nonpreconditioned (group II vs. group I; group VII vs. group V) and preconditioned hearts (group VIII vs. group VI) (Fig. 6), supporting the conclusion that a 4-h reperfusion interval is sufficient to evaluate ischemic PC in the mouse. This information should be useful in designing future studies, particularly studies of early PC, which could be done acutely without the need for survival surgery. In conclusion, with the development of genetically engineered mice, there is increasing interest in the use of transgenic or knockout mice as a tool to interrogate the cellular mechanisms of cardiovascular disease. Through overexpression or targeted disruption of specific genes, these murine models provide a unique approach to understanding the role of specific gene products in abnormal cardiovascular function. In the case of ischemic PC, however, the exploitation of genetic manipulations has been hindered by the lack of in vivo physiological correlates. The present study describes a new mouse model of both early and late ischemic PC, in which several fundamental physiological variables are carefully controlled and kept within normal limits. Mortality is relatively low (<20%). Measurements of infarct size are accurate and reproducible. Our results demonstrate that a robust infarct-sparing effect occurs during the early and the late phases of PC in the mouse and that the quantitative aspects of this effect are consistent with prior experience in other species. This murine model should be useful for elucidating the cellular mechanisms of ischemic PC by making it possible to apply molecular biology techniques to intact animal preparations to dissect the precise roles of individual proteins.| |
ACKNOWLEDGEMENTS |
|---|
We gratefully acknowledge Gregg Shirk and Dr. Weike Bao for expert technical assistance and Trudy Keith for expert secretarial assistance.
| |
FOOTNOTES |
|---|
This study was supported in part by National Heart, Lung, and Blood Institute Grants R01 HL-43151 and HL-55757 (R. Bolli); Kentucky American Heart Association Affiliate Grants KY-96-GB32 (Y. Qiu), KY-96-GB31 (X.-L. Tang), and KY-9804557 (Y. Guo); and the Medical Research Grant Program of the Jewish Hospital Foundation, Louisville, KY.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: R. Bolli, Univ. of Louisville, Div. of Cardiology, Louisville, KY 40292.
Received 3 April 1998; accepted in final form 21 May 1998.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
1.
Auchampach, J. A.,
and
G. J. Gross.
Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs.
Am. J. Physiol.
264 (Heart Circ. Physiol. 33):
H1327-H1336,
1993
2.
Auchampach, J.,
A. Rizvi,
Y. Qiu,
X.-L. Tang,
C. Maldonado,
S. Teschner,
and
R. Bolli.
Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl) adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits.
Circ. Res.
80:
800-809,
1997
3.
Baxter, G. F.,
F. M. Goma,
and
D. M. Yellon.
Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium.
Br. J. Pharmacol.
115:
222-224,
1995[Medline].
4.
Baxter, G. F.,
F. M. Goma,
and
D. M. Yellon.
Characterisation of the infarct-limiting effect of delayed preconditioning: time course and dose-dependency studies in rabbit myocardium.
Basic Res. Cardiol.
92:
159-167,
1997[Medline].
5.
Baxter, G. F.,
M. S. Marber,
V. C. Patel,
and
D. M. Yellon.
Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning.
Circulation
90:
2993-3000,
1994
6.
Baxter, G. F.,
M. M. Mocanu,
and
D. M. Yellon.
Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivo.
J. Mol. Cell. Cardiol.
29:
1967-1975,
1997[Medline].
7.
Birnbaum, Y.,
S. L. Hale,
and
R. A. Kloner.
Differences in reperfusion length following 30 min of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining.
J. Mol. Cell. Cardiol.
29:
657-666,
1997[Medline].
8.
Bolli, R.
The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview.
Basic Res. Cardiol.
91:
57-63,
1996[Medline].
9.
Bolli, R.,
Z. A. Bhatti,
X.-L. Tang,
Y. Qiu,
Q. Zhang,
Y. Guo,
and
A. K. Jadoon.
Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide.
Circ. Res.
81:
42-52,
1997
10.
Bolli, R.,
S. Manchikalapudi,
X.-L. Tang,
H. Takano,
Y. Qiu,
Q. Zhang,
Y. Guo,
and
A. K. Jadoon.
The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as mediator of the late phase of preconditioning.
Circ. Res.
81:
1094-1107,
1997
11.
Burckhartt, B.,
X. M. Yang,
A. Tsuchida,
K. M. Mullane,
J. M. Downey,
and
M. V. Cohen.
Acadesine extends the window of protection afforded by ischemic preconditioning in conscious rabbits.
Cardiovasc. Res.
29:
653-657,
1995[Medline].
12.
Chien, G. L.,
R. A. Wolff,
R. F. Davis,
and
D. M. van Winkle.
"Normothermic range" temperature affects myocardial infarct size.
Cardiovasc. Res.
28:
1014-1017,
1994
13.
Cohen, M. V.,
and
J. M. Downey.
Preconditioning during ischemia.
Cardiol. Rev.
3:
137-149,
1995.
14.
Cohen, M. V.,
X. M. Yang,
and
J. M. Downey.
Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning.
Circ. Res.
74:
998-1004,
1994
15.
Das, D. K.
Preconditioning potentiates molecular signaling for myocardial adaptation to ischemia.
Ann. NY Acad. Sci.
793:
191-209,
1996[Medline].
16.
Downey, J. M.
lschemic preconditioning: nature's own cardioprotective intervention.
Trends Cardiovasc. Med.
2:
170-176,
1992.
17.
Duncker, D. J.,
C. L. Klassen,
Y. Ishibashi,
S. H. Herrlinger,
T. J. Pavek,
and
R. J. Bache.
Effect of temperature on myocardial infarction in swine.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H1189-H1199,
1996
18.
Erhardt, W.,
A. Hebestedt,
G. Aschenbrenner,
B. Pichotka,
and
G. Blumel.
A comparative study with various anesthetics in mice (pentobarbitone, ketamine-xylazine, carfentanyl-etomidate).
Res. Exp. Med. (Berl.)
184:
159-169,
1984[Medline].
19.
Fukamizu, A.,
K. Sugimura,
E. Takimoto,
F. Sugiyama,
M. S. Seo,
S. Takahashi,
T. Hatae,
N. Kajiwara,
K. Yagami,
and
K. Murakami.
Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes.
J. Biol. Chem.
268:
11617-11621,
1993
20.
Hale, S. L.,
and
R. A. Kloner.
Myocardial temperature in acute myocardial infarction: protection with mild regional hypothermia.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H220-H227,
1997
21.
Huang, P. L.,
Z. Huang,
H. Mashimo,
K. D. Bloch,
M. A. Moskowitz,
J. A. Bevan,
and
M. C. Fishman.
Hypertension in mice lacking the gene for endothelial nitric oxide synthase.
Nature
377:
239-242,
1995[Medline].
22.
Hutter, J. J.,
R. Mestril,
E. K. Tam,
R. E. Sievers,
W. H. Dillmann,
and
C. L. Wolfe.
Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo.
Circulation
94:
1408-1411,
1996
23.
Imagawa, J.,
G. F. Baxter,
and
D. M. Yellon.
Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit.
J. Mol. Cell. Cardiol.
29:
1883-1893,
1996.
24.
Jagasia, D., J. M. Whiting, and P. H. McNulty. Ischemic preconditioning fails to produce a second window
of protection 24 hrs later in the rat (Abstract).
Circulation 94, Suppl. I: I-184, 1996.
25.
Kaplan, H. M.,
N. R. Brewer,
and
W. H. Blair.
The cardiovascular system. Normative biology, immunology, and husbandry.
In: The Mouse in Biomedical Research, edited by H. L. Foster,
J. D. Small,
and J. G. Fox. New York: Academic, 1983, vol. 3, p. 248-265.
26.
Kuro-o, M.,
K. Hanaoka,
Y. Hiroi,
T. Noguchi,
Y. Fujimori,
S. Takewaki,
M. Hayasaka,
H. Katoh,
A. Miyagishi,
R. Nagai,
Y. Yazaki,
and
Y. Nabeshima.
Salt-sensitive hypertension in transgenic mice overexpressing Na+-proton exchanger.
Circ. Res.
76:
148-153,
1995
27.
Kuzuya, T.,
S. Hoshida,
N. Yamashita,
H. Fuji,
H. Oe,
M. Hon,
T. Kamada,
and
M. Tada.
Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia.
Circ. Res.
72:
1293-1299,
1993
28.
Lopez, M. J.,
S. K. F. Wong,
I. Kishimoto,
S. Dubois,
V. Mach,
J. Friesen,
D. L. Garbers,
and
A. Beuve.
Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide.
Nature
378:
65-68,
1995[Medline].
29.
Maldonado, C.,
Y. Qiu,
X.-L. Tang,
M. V. Cohen,
J. Auchampach,
and
R. Bolli.
Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H1324-H1332,
1997
30.
Marber, M. S.,
D. S. Latchman,
J. M. Walker,
and
D. M. Yellon.
Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction.
Circulation
88:
1264-1272,
1993
31.
Marber, M. S.,
and
D. M. Yellon.
Myocardial adaptation, stress proteins, and the second window of protection.
Ann. NY Acad. Sci.
793:
123-141,
1996[Medline].
32.
Michael, L. H.,
M. L. Entman,
C. J. Hartley,
K. A. Youker,
J. Zhu,
S. R. Hall,
H. K. Hawkins,
K. Berens,
and
C. M. Ballantyne.
Myocardial ischemia and reperfusion: a murine model.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H2147-H2154,
1995
33.
Murry, C. E.,
R. B. Jennings,
and
K. A. Reimer.
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Circulation
74:
1124-1136,
1986
34.
Ohkubo, H.,
H. Kawakami,
Y. Kakehi,
T. Takumi,
H. Arai,
Y. Yokota,
M. Iwai,
Y. Tanabe,
M. Masu,
J. Hata,
H. Iwao,
H. Okamoto,
M. Yokoyama,
T. Nomura,
M. Katsuki,
and
S. Nakanishi.
Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes.
Proc. Natl. Acad. Sci. USA
87:
5153-5157,
1990
35.
Patel, B. S.,
M. O. Jeroudi,
P. G. O'Neill,
R. Roberts,
and
R. Bolli.
Effect of human recombinant superoxide dismutase on canine myocardial infarction.
Am. J. Physiol.
259 (Heart Circ. Physiol. 28):
H369-H380,
1990.
36.
Ping, P.,
J. Zhang,
Y. Qiu,
X.-L. Tang,
S. Manchikalapudi,
X. Cao,
and
R. Bolli.
Ischemic preconditioning induces selective translocation of protein kinase C isoforms 
and 
in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity.
Circ. Res.
81:
404-414,
1997
37.
Qiu, Y.,
P. Ping,
X.-L. Tang,
S. Manchikalapudi,
A. Rizvi,
J. Zhang,
H. Takano,
W. J. Wu,
S. Teschner,
and
R. Bolli.
Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that is the isoform involved.
J. Clin. Invest.
101:
2182-2198,
1998[Medline].
38.
Qiu, Y.,
A. Rizvi,
X.-L. Tang,
S. Manchikalapudi,
H. Takano,
A. K. Jadoon,
W. J. Wu,
and
R. Bolli.
Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H2931-H2936,
1997.
39.
Qiu, Y.,
X.-L. Tang,
S. W. Park,
J. V. Sun,
A. Kalya,
and
R. Bolli.
The early and late phases of ischemic preconditioning: a comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion.
Circ. Res.
80:
730-742,
1997
40.
Rizvi, A., Y. Qiu, X.-L. Tang, Y. T. Xuan, H. Takano,
A. K. Jadoon, and R. Bolli. Increased synthesis of
proteins is necessary for the development of late preconditioning
against myocardial stunning in conscious rabbits (Abstract).
Circulation 96, Suppl. I: I-255, 1997.
41.
SAS Institute.
SAS/STAT User's Guide, Release 6.03. Cary, NC: SAS Institute, 1988, p. 675-712.
42.
Schlager, G.
Selection for blood pressure levels in mice.
Genetics
76:
537-549,
1974
43.
Schwartz, L. M.,
S. G. Verbinski,
R. S. Vander Heide,
and
K. A. Reimer.
Epicardial temperature is a major predictor of myocardial infarct size in dogs.
J. Mol. Cell. Cardiol.
29:
1577-1583,
1997[Medline].
44.
Siegmund, O. T.
Some physiologic values.
In: The Merck Veterinary Manual: A Handbook of Diagnosis and Therapy for the Veterinarian. Rahway, NJ: Merck, 1979, p. 1481-1482.
45.
Sun, J. Z.,
X.-L. Tang,
A. A. Knowlton,
S. W. Park,
Y. Qiu,
and
R. Bolli.
Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs.
J. Clin. Invest.
95:
388-403,
1995.
46.
Sun, J. Z.,
X.-L. Tang,
S. W. Park,
Y. Qiu,
J. F. Turrens,
and
R. Bolli.
Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs.
J. Clin. Invest.
97:
562-576,
1996[Medline].
47.
Takahashi, S.,
A. Fukamizu,
T. Hatae,
Y. Yamada,
F. Sugiyama,
N. Kajiwara,
K. Yagami,
and
K. Murakami.
Species-specific kinetics of mouse renin contribute to maintenance of normal blood pressure in transgenic mice with overexpressed human angiotensinogen.
J. Vet. Med. Sci.
54:
1191-1193,
1992[Medline].
48.
Takano, H.,
S. Manchikalapudi,
X.-L. Tang,
Y. Qiu,
A. Rizvi,
A. Jadoon,
Q. Zhang,
and
R. Bolli.
Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits.
Circulation.
98:
441-449,
1998
49.
Tang, X.-L.,
Y. Qiu,
S. W. Park,
J. Z. Sun,
A. Kalya,
and
R. Bolli.
Time-course of late preconditioning against myocardial stunning in conscious pigs.
Circ. Res.
79:
424-434,
1996
50.
Veress, A. T.,
C. K. Chong,
L. J. Field,
and
H. Sonnenberg.
Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high- and low-salt diets.
Am. J. Physiol.
269 (Regulatory Integrative Comp. Physiol. 38):
R186-R192,
1995
51.
Wallenstein, S.,
C. L. Zucker,
and
J. L. Fleiss.
Some statistical methods useful in circulation research.
Circ. Res.
47:
1-9,
1996
52.
Wang, J.,
W. Xiong,
Z. Yang,
T. Davis,
M. J. Dewey,
J. Chao,
and
L. Chao.
Human tissue kallikrein induces hypotension in transgenic mice.
Hypertension
23:
236-243,
1994
53.
Weinbrenner, C.,
G. S. Liu,
M. V. Cohen,
and
J. M. Downey.
Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
J. Mol. Cell. Cardiol.
29:
2383-2391,
1996.
54.
Wolfensohn, S.,
and
M. Lloyd.
Biological data.
In: Handbook of Laboratory Animal Management and Welfare. Oxford, UK: Oxford University Press, 1996, p. 114-117.
55.
Yang, X. M.,
G. F. Baxter,
R. J. Heads,
D. M. Yellon,
J. M. Downey,
and
M. V. Cohen.
Infarct limitation of the second window of protection in a conscious rabbit model.
Cardiovasc. Res.
31:
777-783,
1996[Medline].
56.
Ytrehus, K.,
Y. Liu,
and
J. M. Downey.
Preconditioning protects ischemic rabbit heart by protein kinase C activation.
Am. J. Physiol.
266 (Heart Circ. Physiol. 35):
H1145-H1152,
1994
This article has been cited by other articles:
|
|
 |
|
  I. J. Benjamin, Y. Guo, S. Srinivasan, S. Boudina, R. P. Taylor, N. S. Rajasekaran, R. Gottlieb, E. F. Wawrousek, E. D. Abel, and R. Bolli CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3201 - H3209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhu, B. Liu, S. Zhou, Y.-R. Chen, Y. Deng, J. L. Zweier, and G. He Ischemic preconditioning prevents in vivo hyperoxygenation in postischemic myocardium with preservation of mitochondrial oxygen consumption Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1442 - H1450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Boengler, I. Konietzka, A. Buechert, Y. Heinen, D. Garcia-Dorado, G. Heusch, and R. Schulz Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43 Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1764 - H1769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Eckle, A. Grenz, D. Kohler, A. Redel, M. Falk, B. Rolauffs, H. Osswald, F. Kehl, and H. K. Eltzschig Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2533 - H2540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-L. Tang, H. Sato, S. Tiwari, B. Dawn, Q. Bi, Q. Li, G. Shirk, and R. Bolli Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2308 - H2317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Cai, J. M. Holm, I. J. Duignan, J. Zheng, M. Xaymardan, A. Chin, V. L. T. Ballard, J. N. Bella, and J. M. Edelberg BDNF-mediated enhancement of inflammation and injury in the aging heart Physiol Genomics, February 23, 2006; 24(3): 191 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Li, Y. Guo, W. Tan, A. B. Stein, B. Dawn, W.-J. Wu, X. Zhu, X. Lu, X. Xu, T. Siddiqui, et al. Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H584 - H589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zheng, A. Chin, I. Duignan, K.-H. Won, M. K. Hong, and J. M. Edelberg Growth factor-mediated reversal of senescent dysfunction of ischemia-induced cardioprotection Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H525 - H530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. E. Konstantinov, S. Arab, J. Li, J. G. Coles, C. Boscarino, A. Mori, E. Cukerman, F. Dawood, M. M.H. Cheung, M. Shimizu, et al. The remote ischemic preconditioning stimulus modifies gene expression in mouse myocardium J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1326 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Guo, A. B. Stein, W.-J. Wu, X. Zhu, W. Tan, Q. Li, and R. Bolli Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and {delta}1-opioid receptor agonists is mediated by iNOS Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2251 - H2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wang, D. A. Liem, T. M. Vondriska, H. M. Honda, P. Korge, D. M. Pantaleon, X. Qiao, Y. Wang, J. N. Weiss, and P. Ping Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1290 - H1295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mayr, B. Metzler, Y.-L. Chung, E. McGregor, U. Mayr, H. Troy, Y. Hu, M. Leitges, O. Pachinger, J. R. Griffiths, et al. Ischemic preconditioning exaggerates cardiac damage in PKC-{delta} null mice Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H946 - H956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Guo, A. B. Stein, W.-J. Wu, W. Tan, X. Zhu, Q.-H. Li, B. Dawn, R. Motterlini, and R. Bolli Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1649 - H1653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Song, M. H. Weil, W. Tang, S. Sun, and T. Pellis Cardiopulmonary resuscitation in the mouse J Appl Physiol, October 1, 2002; 93(4): 1222 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Schwanke, I. Konietzka, A. Duschin, X. Li, R. Schulz, and G. Heusch No ischemic preconditioning in heterozygous connexin43-deficient mice Am J Physiol Heart Circ Physiol, October 1, 2002; 283 (4): H1740 - H1742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Zuurbier, V. M. Emons, and C. Ince Hemodynamics of anesthetized ventilated mouse models: aspects of anesthetics, fluid support, and strain Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2099 - H2105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Gabel, R. E. London, C. D. Funk, C. Steenbergen, and E. Murphy Leukocyte-type 12-lipoxygenase-deficient mice show impaired ischemic preconditioning-induced cardioprotection Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H1963 - H1969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Chen, C. C. Chua, Y.-S. Ho, R. C. Hamdy, and B. H. L. Chua Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2313 - H2320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takano, X.-L. Tang, E. Kodani, and R. Bolli Late preconditioning enhances recovery of myocardial function after infarction in conscious rabbits Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2372 - H2381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Morrison, R. Jones, A. M. Byford, A. R. Stell, J. Peart, J. P. Headrick, and G. P. Matherne Transgenic overexpression of cardiac A1 adenosine receptors mimics ischemic preconditioning Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1071 - H1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dana, M. Skarli, J. Papakrivopoulou, and D. M. Yellon Adenosine A1 Receptor Induced Delayed Preconditioning in Rabbits : Induction of p38 Mitogen-Activated Protein Kinase Activation and Hsp27 Phosphorylation via a Tyrosine Kinase- and Protein Kinase C-Dependent Mechanism Circ. Res., May 12, 2000; 86(9): 989 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Meng, B. D. Shames, E. J. Pulido, D. R. Meldrum, L. Ao, K. S. Joo, A. H. Harken, and A. Banerjee Adrenergic induction of bimodal myocardial protection: signal transduction and cardiac gene reprogramming Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1525 - R1533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Zuurbier, V. M. Emons, and C. Ince Hemodynamics of anesthetized ventilated mouse models: aspects of anesthetics, fluid support, and strain Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2099 - H2105. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
, n = 5), only 1 dose of
13.3 ml/kg blood (~0.4 ml) was given (immediately after the chest was
opened). In these mice, mean arterial pressure fell to 63.4 ± 3.7 mmHg after the chest was opened (probably due to the loss of negative
intrathoracic pressure and to positive end-expiratory pressure). After
the chest was closed, blood pressure fell again to a nadir of 63.0 ± 9.7 mmHg. Thus 1 dose of 13.3 ml/kg blood was insufficient to
maintain a stable arterial pressure. In the 2nd group of mice (
,
n = 3), 3 doses of blood were given:
the 1st before the chest was opened, the 2nd immediately after the
chest was opened, and the 3rd after the chest was closed. Each dose
consisted of 13.3 ml/kg (~0.4 ml). With this protocol, mean arterial
blood pressure remained 
, ischemic PC group;
n = 4) was subjected to a sequence of
6 cycles of 4-min coronary occlusion and 4-min reperfusion and was
given 3 doses of blood according to the protocol for the 2nd group. In
the 3rd group, mean arterial pressure was also maintained 
2.55 + 0.57x,
r = 0.87, P < 0.005; group
II, y =